nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—SLC22A7—Organic anion transport—SLC22A12—nephrolithiasis	0.0835	0.209	CbGpPWpGaD
Allopurinol—SLC22A8—Organic anion transport—SLC22A12—nephrolithiasis	0.0702	0.176	CbGpPWpGaD
Allopurinol—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0389	0.0972	CbGpPWpGaD
Allopurinol—SLC22A8—nephron—nephrolithiasis	0.0345	0.188	CbGeAlD
Allopurinol—Angiitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.0332	0.0795	CcSEcCtD
Allopurinol—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0327	0.0817	CbGpPWpGaD
Allopurinol—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.0289	0.0693	CcSEcCtD
Allopurinol—SLC22A8—urine—nephrolithiasis	0.0277	0.151	CbGeAlD
Allopurinol—XDH—Purine metabolism—APRT—nephrolithiasis	0.0208	0.052	CbGpPWpGaD
Allopurinol—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0348	CcSEcCtD
Allopurinol—XDH—renal system—nephrolithiasis	0.0133	0.0725	CbGeAlD
Allopurinol—XDH—kidney—nephrolithiasis	0.0128	0.0701	CbGeAlD
Allopurinol—SLC22A7—renal system—nephrolithiasis	0.0117	0.0639	CbGeAlD
Allopurinol—SLC22A7—kidney—nephrolithiasis	0.0113	0.0617	CbGeAlD
Allopurinol—SLC22A7—cortex of kidney—nephrolithiasis	0.011	0.0601	CbGeAlD
Allopurinol—XDH—Nucleotide metabolism—APRT—nephrolithiasis	0.0105	0.0261	CbGpPWpGaD
Allopurinol—AOX1—nephron tubule—nephrolithiasis	0.00929	0.0507	CbGeAlD
Allopurinol—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00897	0.0215	CcSEcCtD
Allopurinol—AOX1—renal system—nephrolithiasis	0.00845	0.0461	CbGeAlD
Allopurinol—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0201	CcSEcCtD
Allopurinol—AOX1—kidney—nephrolithiasis	0.00817	0.0446	CbGeAlD
Allopurinol—AOX1—cortex of kidney—nephrolithiasis	0.00795	0.0434	CbGeAlD
Allopurinol—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00791	0.019	CcSEcCtD
Allopurinol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00791	0.019	CcSEcCtD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00779	0.0195	CbGpPWpGaD
Allopurinol—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00747	0.0179	CcSEcCtD
Allopurinol—SLC22A8—nephron tubule—nephrolithiasis	0.00744	0.0406	CbGeAlD
Allopurinol—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0175	CcSEcCtD
Allopurinol—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00724	0.0181	CbGpPWpGaD
Allopurinol—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0168	CcSEcCtD
Allopurinol—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0165	CcSEcCtD
Allopurinol—SLC22A8—renal system—nephrolithiasis	0.00677	0.0369	CbGeAlD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00655	0.0164	CbGpPWpGaD
Allopurinol—SLC22A8—kidney—nephrolithiasis	0.00654	0.0357	CbGeAlD
Allopurinol—Gout—Hydrochlorothiazide—nephrolithiasis	0.00648	0.0156	CcSEcCtD
Allopurinol—SLC22A8—cortex of kidney—nephrolithiasis	0.00637	0.0348	CbGeAlD
Allopurinol—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0149	CcSEcCtD
Allopurinol—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00608	0.0152	CbGpPWpGaD
Allopurinol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00595	0.0143	CcSEcCtD
Allopurinol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00588	0.0141	CcSEcCtD
Allopurinol—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0136	CcSEcCtD
Allopurinol—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00547	0.0131	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00511	0.0128	CbGpPWpGaD
Allopurinol—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00505	0.0121	CcSEcCtD
Allopurinol—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00498	0.0119	CcSEcCtD
Allopurinol—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0118	CcSEcCtD
Allopurinol—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00487	0.0117	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00467	0.0117	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00467	0.0117	CbGpPWpGaD
Allopurinol—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00466	0.0112	CcSEcCtD
Allopurinol—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00462	0.0111	CcSEcCtD
Allopurinol—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00456	0.0109	CcSEcCtD
Allopurinol—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0106	CcSEcCtD
Allopurinol—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0105	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00429	0.0107	CbGpPWpGaD
Allopurinol—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0102	CcSEcCtD
Allopurinol—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00991	CcSEcCtD
Allopurinol—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00987	CcSEcCtD
Allopurinol—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00963	CcSEcCtD
Allopurinol—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.004	0.00959	CcSEcCtD
Allopurinol—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00953	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00949	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00392	0.00982	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00392	0.00982	CbGpPWpGaD
Allopurinol—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00933	CcSEcCtD
Allopurinol—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00917	CcSEcCtD
Allopurinol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00887	CcSEcCtD
Allopurinol—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00852	CcSEcCtD
Allopurinol—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00852	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00354	0.00885	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00354	0.00885	CbGpPWpGaD
Allopurinol—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00839	CcSEcCtD
Allopurinol—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00829	CcSEcCtD
Allopurinol—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00822	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00805	CcSEcCtD
Allopurinol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00796	CcSEcCtD
Allopurinol—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00792	CcSEcCtD
Allopurinol—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00329	0.0079	CcSEcCtD
Allopurinol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00329	0.0079	CcSEcCtD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00329	0.00823	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00329	0.00823	CbGpPWpGaD
Allopurinol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00779	CcSEcCtD
Allopurinol—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00323	0.00774	CcSEcCtD
Allopurinol—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00766	CcSEcCtD
Allopurinol—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00758	CcSEcCtD
Allopurinol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00742	CcSEcCtD
Allopurinol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00731	CcSEcCtD
Allopurinol—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00304	0.00729	CcSEcCtD
Allopurinol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00726	CcSEcCtD
Allopurinol—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00724	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00297	0.00744	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00297	0.00744	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00293	0.00734	CbGpPWpGaD
Allopurinol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00293	0.00703	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00291	0.00728	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00291	0.00728	CbGpPWpGaD
Allopurinol—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00689	CcSEcCtD
Allopurinol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0068	CcSEcCtD
Allopurinol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00677	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00276	0.00692	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00276	0.00692	CbGpPWpGaD
Allopurinol—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00644	CcSEcCtD
Allopurinol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00625	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00259	0.00649	CbGpPWpGaD
Allopurinol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00622	CcSEcCtD
Allopurinol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00595	CcSEcCtD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00246	0.00617	CbGpPWpGaD
Allopurinol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00589	CcSEcCtD
Allopurinol—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00587	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00245	0.00612	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00245	0.00612	CbGpPWpGaD
Allopurinol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00583	CcSEcCtD
Allopurinol—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0058	CcSEcCtD
Allopurinol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00572	CcSEcCtD
Allopurinol—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00238	0.0057	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00237	0.00594	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00237	0.00594	CbGpPWpGaD
Allopurinol—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00568	CcSEcCtD
Allopurinol—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0054	CcSEcCtD
Allopurinol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0054	CcSEcCtD
Allopurinol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00534	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00218	0.00545	CbGpPWpGaD
Allopurinol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00522	CcSEcCtD
Allopurinol—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00518	CcSEcCtD
Allopurinol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00518	CcSEcCtD
Allopurinol—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00507	CcSEcCtD
Allopurinol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00501	CcSEcCtD
Allopurinol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00494	CcSEcCtD
Allopurinol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00484	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00199	0.00499	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00199	0.00499	CbGpPWpGaD
Allopurinol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00197	0.00472	CcSEcCtD
Allopurinol—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00469	CcSEcCtD
Allopurinol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00465	CcSEcCtD
Allopurinol—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00461	CcSEcCtD
Allopurinol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00456	CcSEcCtD
Allopurinol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00188	0.0045	CcSEcCtD
Allopurinol—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00443	CcSEcCtD
Allopurinol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00443	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0018	0.0045	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0018	0.0045	CbGpPWpGaD
Allopurinol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00427	CcSEcCtD
Allopurinol—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00177	0.00424	CcSEcCtD
Allopurinol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00412	CcSEcCtD
Allopurinol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00171	0.0041	CcSEcCtD
Allopurinol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00171	0.0041	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00167	0.00418	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00167	0.00418	CbGpPWpGaD
Allopurinol—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00382	CcSEcCtD
Allopurinol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00155	0.00372	CcSEcCtD
Allopurinol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00367	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00151	0.00378	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00151	0.00378	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00149	0.00373	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00149	0.00373	CbGpPWpGaD
Allopurinol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00354	CcSEcCtD
Allopurinol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00143	0.00343	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00141	0.00351	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00141	0.00351	CbGpPWpGaD
Allopurinol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00329	CcSEcCtD
Allopurinol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00327	CcSEcCtD
Allopurinol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00326	CcSEcCtD
Allopurinol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00325	CcSEcCtD
Allopurinol—AOX1—Metabolism—GRHPR—nephrolithiasis	0.00135	0.00337	CbGpPWpGaD
Allopurinol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00308	CcSEcCtD
Allopurinol—XDH—Metabolism—GRHPR—nephrolithiasis	0.00125	0.00313	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00125	0.00313	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00125	0.00313	CbGpPWpGaD
Allopurinol—AOX1—Disease—SLC26A1—nephrolithiasis	0.00122	0.00305	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—AGXT—nephrolithiasis	0.0012	0.003	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00119	0.00298	CbGpPWpGaD
Allopurinol—XDH—Metabolism—AGXT—nephrolithiasis	0.00112	0.00279	CbGpPWpGaD
Allopurinol—AOX1—Disease—ATP6V0A4—nephrolithiasis	0.00109	0.00272	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—APRT—nephrolithiasis	0.00102	0.00255	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—SLC26A1—nephrolithiasis	0.00102	0.00255	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.001	0.0025	CbGpPWpGaD
Allopurinol—XDH—Metabolism—APRT—nephrolithiasis	0.000949	0.00238	CbGpPWpGaD
Allopurinol—XDH—Metabolism—SLC26A1—nephrolithiasis	0.000949	0.00238	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—AQP1—nephrolithiasis	0.000728	0.00182	CbGpPWpGaD
Allopurinol—XDH—Metabolism—AQP1—nephrolithiasis	0.000676	0.00169	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—CHRM3—nephrolithiasis	0.000658	0.00165	CbGpPWpGaD
Allopurinol—XDH—Metabolism—CHRM3—nephrolithiasis	0.000612	0.00153	CbGpPWpGaD
